» Articles » PMID: 1279221

Establishment and Characterization of a Human Primary Prostatic Adenocarcinoma Cell Line (ND-1)

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 1992 Nov 1
PMID 1279221
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

A human primary prostatic adenocarcinoma cell line named ND-1 has been established in long term tissue culture. The cultured cells show growth in both monolayers and in soft agar suspension and produce subcutaneous tumors in nude mice. Cytogenetic analysis by G-banding demonstrated an aneuploid karyotype with a modal chromosome number of 62, and multiple marker chromosomes with 25-30% structural abnormalities. Ploidy analysis revealed that the majority of ND-1 cells (67%) had a DNA mass of 10.1 picogram and DNA index of 1.41. Nineteen percent of cells had a DNA mass of 21.3 picogram and DNA index of 3.0. Electron microscopic studies revealed common features of neoplastic epithelial cells such as numerous microvilli, junctional complexes, abnormal nuclei, nucleoli, and mitochondria. Due to the absence of a structurally normal Y chromosome, confirmation of the presence of a derived Y chromosome was achieved through the use of C-banding and through fluorescent in situ hybridization with a Y chromosome repeat probe. Tandem E PSA immunoenzymatic assay revealed that these ND-1 cells secrete small amounts of prostate specific antigen.

Citing Articles

Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells.

Namekawa T, Ikeda K, Horie-Inoue K, Inoue S Cells. 2019; 8(1).

PMID: 30669516 PMC: 6357050. DOI: 10.3390/cells8010074.


Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures.

Vicentini C, Festuccia C, Gravina G, Angelucci A, Marronaro A, Bologna M J Cancer Res Clin Oncol. 2003; 129(3):165-74.

PMID: 12712332 DOI: 10.1007/s00432-003-0420-3.


A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49.

True L, Buhler K, Quinn J, Williams E, Nelson P, Clegg N Am J Pathol. 2002; 161(2):705-15.

PMID: 12163395 PMC: 1850754. DOI: 10.1016/S0002-9440(10)64226-5.


A new human prostate carcinoma cell line, 22Rv1.

Sramkoski R, Pretlow 2nd T, Giaconia J, Pretlow T, Schwartz S, Sy M In Vitro Cell Dev Biol Anim. 1999; 35(7):403-9.

PMID: 10462204 DOI: 10.1007/s11626-999-0115-4.


Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1.

Hayward S, Dahiya R, Cunha G, Bartek J, Deshpande N, Narayan P In Vitro Cell Dev Biol Anim. 1995; 31(1):14-24.

PMID: 7535634 DOI: 10.1007/BF02631333.